|
Recent Developments |
|
31-MAY-18
Granules Pharmaceuticals, Inc., the wholly owned subsidiary of Granules lndia, has launched the generic version of Methylergonovine Maleate Tablets, USP, 0.2mg, the generic equivalent to Methergine in partnership with West Ward Pharmaceuticals Corp. (West-Ward), a wholly-owned subsidiary of Hikma Pharmaceuticals PLC (Hikma).
24-MAY-18
Granules India announced a substantial drop in consolidated net profit for the quarter ended March 2... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2014(9) | 31-Mar-2014 (12) | 31-Mar-2013 (12) | | Net sales | 8446.96 | 10016.80 | 6797.97 | | Other Income | 15.46 | 36.48 | 17.18 | | Total Income | 8462.42 | 10053.28 | 6815.15 | | Cost of goods sold | 6843.04 | 8386.73 | 6007.39 | | OPBDIT | 1619.38 | 1666.55 | 807.76 | | PAT | 728.46 | 810.11 | 301.75 | | Gross Block | - | - | - | | Equity capital | 204.25 | 202.81 | 201.26 | | EPS (Rs.) | - | 40.06 | 15.02 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 2.35 - 7.34 | 5.26 - 15.61 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 19.1 | 16.6 | 11.9 | | Net margin (% of OI) | 8.6 | 8.1 | 4.4 |
|
|
Detailed Financials
|
|
|
|
|
